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2 Summary 
Milbeknock is a new insecticide/acaricide containing the new active substance milbemectin, 
which is a microbial fermentation product of Streptomyces. It is applied for control of mites 
and leafminers. The intended use is as a foliar spray in fruits (apples/pears), strawberries (only 
after harvest) and in ornamental plants growing in greenhouse and outdoors. The risk 
assessment was finalized at a meeting November 24, 2011, by VKM’s Scientific Panel on 
plant protection products (Panel 2). Panel 2 is in particular asked by the Norwegian Food 
Safety Authority to look at the following: 1) The human health risk for operators related to the 
properties of the active substance and the product. 2) The degree of oral absorption. 3) Acute 
toxicity. 4) The reproduction and developmental toxicity. 5) Establishment of reference 
values (ADI, AOEL and ARfD). 6) The fate and behaviour in the environment and 
environmental risk with regard to the properties of Milbeknock and milbemectin. 7) 
Bioavailability of milbemectin. 8) The microcosm study. 
 
VKM Panel 2’s conclusion is as follows:  
Health 
Panel 2 proposes to set the absorption to 50%, which is in agreement with the EU DAR report 
(propose 47%). For acute toxicicity, Panel 2 concludes that milbemectin probably has a LD50 
for dogs between 100 and 200 mg/kg body weight (bw)/day. Dogs seem to be the most 
sensitive experimental species and should be considered for hazard classification purposes. 
With respect to reproduction and developmental toxicity, Panel 2 concludes that the 
documentation of the role of the P-glycoprotein transporter is not convincing, and that the CF-
1 mice study cannot be used to support the argumentation of no developmental toxicity put 
forward by the applicant. The following reference values have been estimated: ADI of 0.03 
mg/kg bw/day; AOEL of 0.015 mg/kg bw/day and ARfD of 0.067 mg/kg bw/day for 
milbemectin. Provided that personal protection equipment is used, the AOEL for operators is 
not exceeded. 
 
Environment 
With respect to environmental fate, the opinion of the Panel is that the relatively rapid 
degradation in soil indicates a significant bioavailability in both soil and water-sediment 
systems. Further it concludes that 0.058µg/L should be regarded as NOECpopulation for the 
microcosm study. Panel 2 concludes that there is a medium risk of toxic effects on aquatic 
organisms due to exposure of milbemectin sprayed in fruits with the proposed application 
regime, provided that a buffer zone of 30 meters to surface water is applied. There are 
minimal risks of toxic effects on aquatic organisms with sufficient buffer zones in other 
applied crops. Panel 2 further considers the risk for foliage dwelling non-target predators and 
parasitoids to be high, and the risk to earthworms to be medium. 
The strong sorption to soil suggests that the bioavailability in soil may be limited. However, 
the opinion of the Panel is that the relatively rapid degradation in soil indicates a significant 
bioavailability. Also, for a substance with such a high log Kow the reported water solubility is 
relatively high, which will contribute to the availability for biological uptake. The toxicity 
observed in the microcosm study indicates high bioavailability also in a water/sediment 
system.  
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3 Background 
VKM performs risk assessments in the context of pesticide registration cf. Regulation on 
Pesticides § 4. The Norwegian Food Safety Authority, National Registration Section, is 
responsible for reviewing and evaluating the documentation submitted by the pesticide 
notifier. The Norwegian Food Safety Authority takes the final regulatory action regarding 
registration or deregistration of pesticides based on VKMs risk assessment, along with a 
comparative assessment of risk and benefits and the availability of alternatives (the principle 
of substitution).  
The Norwegian Food Safety Authority submitted a request on October 18, 2011 for VKM to 
perform a risk assessment on use of the pesticide Milbeknock containing the active substance 
milbemectin. Both the environmental and the health risk assessments of the product were 
finalized by VKM’s Panel 2 at a meeting on November 24, 2011. 
 
4 Terms of reference 
Milbeknock is a new insecticide/acaricide in Norway containing the active substance 
milbemectin, and is applied for control of mites and leafminers. The intended use is as a foliar 
spray in fruits (apples/pears), strawberries (only after harvest) and in ornamental plants 
growing in glasshouses and outdoors. In connection with this, The Norwegian Food Safety 
Authority would like an assessment of the human health risk for operators related to the 
properties of the active substance and the product and the fate and behaviour in the 
environment and environmental risk. Panel 2 is in particular asked to look at the following: 
• The human health risk for operators related to the properties of the active substance and 
the product. Panel 2 is in particular asked to look at the following:  
o The degree of oral absorption. 
o Acute toxicity.  
o The reproduction and developmental toxicity.  
o Establishment of reference values (ADI, AOEL and ARfD).  
• The fate and behaviour in the environment and environmental risk with regard to the 
properties of Milbeknock and milbemectin. Panel 2 is particularly asked to look at the 
following: 
o Bioavailability of milbemectin  
o The microcosm study. 
 
5 Risk Assessment 
5.1 BACKGROUND DOCUMENTATION 
Panel 2’s risk assessment is based on the Norwegian Food Safety Authority’s evaluation 
(2011) of the documentation submitted by the applicant. The Norwegian Food Safety 
Authority publishes both their evaluation of Milbeknock and their final regulatory action on 
the registration of the pesticide product at their homepage www.Mattilsynet.no 
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5.2 PROCEDURE 
The first three steps of the risk assessment (hazard identification, hazard characterization and 
assessment of exposure) are performed by the Norwegian Food Safety Authority and involve 
an assessment of the documentation submitted by the pesticide notifier. The resulting report 
on hazard identification, hazard characterization and assessment of exposure, from which the 
summary is included in the present document, is then reviewed by VKMs Panel 2. This 
review may result in some amendments in the original documents of both the summary and 
the full report issued by the Norwegian Food Safety Authority (2011). The fourth step (risk 
characterization) is based on the three first steps and is Panel 2’s conclusions or risk 
assessment.  
 
5.2.1 HEALTH RISK ASSESSMENT 
The assessment of health risk of pesticides is based on the adverse effects produced by the 
active substance and product in several experimental test systems including long term animal 
studies. On the basis of this, limits of exposure which represent no health risk are determined. 
The limits take account of the uncertainties of extrapolating data for animal to human. Then 
the limits are compared to the operator exposure and human exposure to possible residues in 
food.  
The UKPoem and the German model estimate of exposure are used to estimate the operator 
exposure. The models are based on a limited number of studies and are not validated. Thus, 
the models may not always be sufficiently representative for Norwegian conditions. The 
limitations of model estimates of exposure are taken into consideration when the calculated 
level of exposure is close to the threshold limit for acceptable operator exposure (Acceptable 
Operator Exposure Level; AOEL). Panel 2 uses the 75 percentile of exposure assessment for 
both UK poem and German model. Panel 2 has to base their assessment on the models 
whenever exposure data for the product is not presented.  
Panel 2 makes use of a higher safety factor when calculating AOEL and ADI in cases where 
the product contains critical active substances with serious adverse inherent properties (toxic 
to reproduction or carcinogenic). 
In order to describe the exceeding of maximum tolerated dose, Panel 2 makes use of a scale. 
The scale is based on the ratio between the estimated exposure based on models or measured 
exposure in field studies and the Acceptable Operator Exposure Level (AOEL). In case the 
estimated exposure significantly exceeds AOEL, use of the products may lead to increased 
risk for health effects.  
 
The following scale is used: 
Very high excess of AOEL more than 500% of the limit   
High excess of AOEL  300 – 500% of the limit  
Medium excess of AOEL 150-300% of the limit  
Moderate excess of AOEL  100-150% of the limit    
The limit is not exceeded 
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Panel 2 may take into consideration critical co-formulants of the product when the degree of 
risk is to be determined. Consequently, if a product contains critical co-formulants it may be 
assessed to represent higher risk than what the inherent properties of active substances imply.   
 
5.2.2 ENVIRONMENTAL RISK ASSESSMENT 
The environmental risk assessment of pesticides involves predictions of exposure 
concentrations in various environmental compartments (e.g. soil and surface waters) that may 
occur after application of the pesticide. These predicted effect concentrations (PECs) are 
compared to exposure levels that are known to cause toxic effects to important groups of 
organisms representing the environmental compartments.  
The environmental fate and possible ecotoxicological effects of pesticides are investigated in 
several laboratory- and field experiments. In environmental risk assessments of pesticides, 
Predicted Environmental Concentrations (PECs) are estimated by use of different scenarios 
for different parts of the environment (terrestrial, aquatic). The first parameter estimated is 
usually the initial concentration (PIEC, Predicted Initial Environmental Concentration), e.g. 
the concentration just after application (usually spraying). PIEC in soil is calculated assuming 
a homogenous distribution of areal dose in the upper 5 cm soil layer. For surface water, the 
PIEC is based on deposition of pesticides from spray drift in a standard size water body. The 
calculations are performed with application of buffer zones between the sprayed area and the 
water body. 
The further exposure regime in different compartments is affected on the fate of the pesticide. 
The fate is dependent on processes such as photodegradation, hydrolysis, biodegradation and 
sorption to soil particles. These processes are studied in several standardised laboratory tests. 
In addition, field tests are used to study the dissipation of the pesticide in various agricultural 
soils. Based on the experimental fate studies, factors describing different fate processes may 
be derived and used in models that describe the fate of the pesticide in the soil as well as the 
transport to surface water and ground water. The concentrations of the pesticide in water are 
estimated by use of models with relevant scenarios based on EU’s FOCUS-scenarios. The 
models produce maximum PEC and average PEC calculated for specified periods after 
pesticide application. In the surface water scenarios PEC is also calculated for the sediment 
phase. 
Then the Toxicity Exposure Ratio (TER) is estimated for different groups of organisms. The 
TER is calculated as the ratio between the toxicity for the organism in question (expressed as 
LC50, EC50, NOEC etc., depending on organism and study type) and PEC or PIEC. Trigger 
values for TER, which express the acceptability of the risk for different organisms, have been 
defined by the EU. The risk is considered minimal when the TER does not exceed the trigger 
value.  
In the terrestrial environment, the risk for toxic effects on bees and non-target arthropods is 
assessed according to other criteria. Hazard quotients for oral- (HQO) and contact toxicity 
(HQC) are estimated for bees. HQO evt. HQC is the ratio between the standardized area dose of 
the product (g v.s./ha) and acute toxicity for the bee (LD50, µg active ingredient/bee). Field 
experiments and expert evaluation is triggered whenever the hazard quotient is above 50.  
For the non-target arthropods, the estimated hazard quotient (HQ) is the ratio between the 
area dose of the product (g active ingredient/ha), which is multiplied with a factor for multiple 
applications (MAF, multiple application factor) when appropriate, and the acute toxicity for 
the organism (LR50, g active ingredient/ha). According to EU, whenever the ratio value 
exceeds 2, further investigations are triggered.  
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Panel 2 makes use of a scale in order to describe the risk of exposure for different organisms 
which live within and outside the spraying field. The scale is based on the ratio between the 
estimated exposure and the limit or the ratio between the TER and the TER trigger value 
designated each group of organism.  
The following risk scale is used:  
Very high risk  more than 500% of the limit   
High risk  300 – 500% of the limit  
Medium risk   150-300% of the limit  
Moderate risk  110-150% of the limit 
Minimal risk   the limit is not exceeded 
The estimates of exposure concentrations are based on maximal concentrations, which exist 
during or shortly after spraying. The group of organism assessed (for example birds or leaf 
dwelling non-target organisms) is not always present during the period of maximal 
concentration. In the final risk assessment, Panel 2 therefore takes into consideration whether, 
or to which extent, the organism in question actually will be exposed. This may cause that the 
risk is assessed lower than indicated by the scale above.  
Additionally, uncertainties in the data base both with regard to establishments of limits and 
models of exposure concentrations are taken into consideration if relevant. This may also 
cause that the risk is assessed lower or higher than the risk scale. Any deviation from the risk 
scale is justified in this document.  
 
5.3 SUMMARY BY THE NORWEGIAN FOOD SAFETY AUTHORITY (HAZARD 
IDENTIFICATION, HAZARD CHARACTERIZATION AND ASSESSMENT OF 
EXPOSURE) 
Milbeknock is a new product containing the new active substance milbemectin, which is 
consisting of the microbial fermentation products of Streptomyces. Milbeknock is an 
emulsifiable concentrate (EC) formulation containing 9.3 g/L of the active ingredient.  
 
The product is an acaricide/insecticide, and is applied for control of mites and leafminers. The 
intended use is as a foliar spray in fruits (apples/pears), strawberries (only after harvest) and 
in ornamental plants growing in glasshouses and outdoors. 
 
The Standardised Area Dose is 250 ml product (2.33 g milbemectin) per decare, and is based 
on the applied use in strawberries. The recommended maximum dose rate in fruits 
(apple/pear) is 190 ml product (1.77 g milbemectin) per decare depending of tree height. In 
ornamentals the recommended maximum dose rate is 200 ml product (1.86 g milbemectin) 
per decare. 
The product is applied for spraying at a maximum frequency of up to two times in fruits and 
berries and up to four times in ornamentals.  
Spider mites and Liriomyza species (leafminers) have in general high risk of developing 
resistance to chemical agents. To ensure maximum and prolonged effectiveness and to 
minimize the likelihood of resistant strains of pests developing, it is recommended that 
products with a different mode of action are incorporated into annual spray programs.  
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The product is harmful for several biological control agents used for mite control, and this 
should be instructed on the label. 
 
5.3.1 IDENTITY AND PHYSICAL/CHEMICAL DATA 
Product name Milbeknock 
 
Active substance milbemectin 
 
Formulation EC formulation 
 
Concentration of  
active substance 9.3 g/Litre 
 
IUPAC-name Milbemectin consists of two milbemycin isomers: <30% milbemycin A3 
(MA3): (10E,14E,16E,22Z)-(1R,4S,5’S,6R,6’R,8R,13R,20R,21R,24S)-
21,24-dihydroxy-5’,6’,11,13,22-pentamethyl-3,7,19-
trioxatetracyclo[15.6.1.14.8.020,24]pentacosa-10,14,16,22-tetraene-6-spiro-
2’-tetrahydropyran-2-one ;  
and >70% milbemycin A4 (MA4):  
(10E,14E,16E,22Z (10E,14E,16E,22Z)-
(1R,4S,5’S,6R,6’R,8R,13R,20R,21R,24S)-6’-ethyl-21,24-dihydroxy-
5’,11,13,22-tetramethyl-3,7,19-
trioxatetracyclo[15.6.1.14.8.020,24]pentacosa-10,14,16,22-tetraene-6-spiro-
2’-tetrahydropyran-2-one  
 
CAS number        MA3: 51596-10-2; MA4: 51596-11-3 
 
Structural formula 
  
 
 
Molecular weight  
Milbemycin A3     528.7 
Milbemycin A4      542.7 
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Solubility in water 
Milbemycin A3: Moderate,   2.68 mg/l (20 °C) 
Milbemycin A4: Moderate,    4.55 mg/l (20 °C)   
 
Vapour pressure 
Milbemycin A3: Low,   9.7x10-12 Pa (20 °C) 
Milbemycin A4: Low,     4.3x10-10 Pa (20°C) 
 
Henrys law constant 
Milbemycin A3: Low,    2.56x10-3 Pa m3/mol 
Milbemycin A4: Low,    1.55x10-3 Pa m3/mol 
 
log Pow 
Milbemycin A3: Very high,    6.54 (25°C) 
Milbemycin A4: Very high, 7.0 (25°C) 
 
pKa       - 
 
 
5.3.2 MAMMALIAN TOXICOLOGY 
Milbemectin 
Toxicokinetics 
Absorption 
Based on the milbemycin A4 excretion in urine and bile, the absorption seems to be 47 % of a 
single low dose in both sexes and 30/40% in males/females at a single high dose. Thus 
absorption seems to be saturated at higher doses. Peak concentration in blood/plasma was 
reached after 2-3 hours.  
Distribution 
The concentration of the substance was higher in tissues (except brain) than in blood/plasma 
at all time points. Most tissues had a residue peak at 2 hours, but reproductive fat had a peak 
at 6 hours after dosing. Tissue residues increased disproportionately more than the increase in 
dose. Repeated dosing gave the same tissue distribution as single dosing. There was no 
accumulation.  
Metabolism 
Hydroxylation was the main metabolic pathway and different single-, di-, and 
trihydroxymetabolites were formed. The main metabolites were 13-hydroxy-MA3 and –MA4. 
MA3 seems to be more rapidly metabolised than MA4. There was a minor glucuronidation 
pathway.  
  
 
Elimination 
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The main route of elimination was via bile, and a smaller amount was excreted via urine. 
There was a higher percentage of excretion of MA3 than MA4 in urine. Males had higher 
urine excretion than females, especially at low doses. There was rapid excretion the first 24 
hours followed by a prolonged low excretion, and the elimination was more rapid at low dose 
than at high dose (reflected in the concentrations in blood). Repeated dosing gave the same 
elimination pattern as single doses. 
Acute toxicity 
Milbemectin is of moderate acute toxicity in the rat after oral and inhalation exposure and of 
low dermal toxicity. Milbemectin appears more toxic to dogs than to rats. 
 
Irritation/sensitisation 
Milbemectin was not found to be a skin- or eye irritant nor a skin sensitiser. 
 
Genotoxicity 
All in vitro and in vivo genotoxicity studies were negative. Milbemectin is not considered to 
be a genotoxic substance. 
 
Sub-chronic toxicity 
The dog was the most sensitive species with a LOAEL of 10 mg/kg bw/day and the lowest 
NOAEL of 3 mg/kg bw/day. In the short term studies effects on liver, kidney, central nervous 
system and body weight were seen in the rat, mouse and dog. Effects on the adrenals were 
seen in the rat, dog and rabbit (dermal study). Rats had in addition effects on the uterus, testes 
and immune system, but the most sensitive parameter was elevated cholesterol. Elevated 
cholesterol was also seen in dogs. The central nervous system seems relatively more 
vulnerable in the dog than in rodents, in which effects on other organs were seen at lower 
dose levels than effects on the CNS. 
 
Chronic toxicity/oncogenicity 
The long-term toxicity and carcinogenicity study in the rat gave systemic effects as increased 
kidney weight in males and effects on adrenals and uterus in females as the most sensitive 
parameters. At the highest dose level there was also effect on body weight and blood 
parameters. There was an increase in endometrial polyps and adenocarcinomas in the uterus.  
In the mouse elongated incisors, reduced body weight gain and reduced food consumption 
(females only), were seen at 2000 ppm in a 1.5-year oncogenicity study. The central nervous 
system, liver, kidney and adrenals were the target organs. There were no neoplastic changes.  
 
Reproductive toxicity and teratology 
The two-generation study in rats showed effects on parental body weights and food 
consumption in parental animals in the high dose group. The high dose level gave reduced 
litter size and live birth index in the F2 generation. Body weight and body weight gain in the 
lactation period was affected in both F1 and F2 pups. The F2 generation was more affected 
than the F1 generation. There were not seen structural abnormalities in the offspring. In the 
rat, the offspring is more sensitive for milbemectin than the mother. This effects can, 
however, be regarded as not relevant for humans.  
 
In the rat teratogenicity study, the maternal toxicity was manifested by a decrease in mean 
maternal body weight and food consumption. There were no effects on the foetuses.  
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In the rabbit teratogenicity studies, there were seen clinical signs (bradypragia and 
piloerection), reductions in food intake and body weight, deaths, abortions, dead foetuses and 
reduced foetal weight. There were no teratogenic effects. 
 
Neurotoxicity 
Milbemectin may cause neurotoxic effects of concern.  
In an acute oral neurotoxicity study in dogs, some evidence for neurotoxicity was found. A 
decrease in motor activity was observed at all dose levels; at the lowest tested dose, this 
decreased motoric activity was even observed in the absence of overt systemic toxicity. It 
appears that the observations were not performed during peak time of the neurotoxic effects. 
Therefore a full evaluation of the neurotoxic potential of milbemectin cannot be performed. A 
NOAEL could not be derived in the acute neurotoxicity study. The LOAEL was 20 mg/kg 
bw. Establishment of an ARfD can be based on this study. 
 
Repeated dose administration via the diet did not result in neurotoxic effects in rats at 4, 8, 
and 13 weeks of dosing. Based on the available data a NOAEL of 59 mg/kg bw/d was 
established for repeated dose neurotoxicity of milbemectin in rats. 
 
Special studies 
In a pharmacological study in male rats, mice and rabbits, the results were consistent with an 
action of milbemectin on the central nervous system and at the neuromuscular level. 
 
In another study the abnormal growth of the incisors in rats was investigated. It was found 
that the treated rats moved very slowly and there was barely any attrition. The lack of 
gnawing was the cause of apparent elongation of the incisors. There was no clear explanation 
to why the animals did not gnaw, but many of the possibilities involve effects on the nervous 
system. 
 
In a third study the involvement of P-glycoprotein in the absorption of milbemectin through 
Caco-2 monolayers was determined. However, it was not possible to monitor the 
concentration of milbemectin due to high non-specific binding of MA3 and MA4 to the 
polystyrene and polypropylene plates in the experimental apparatus. 
 
An acute oral toxicity study in female CF-1 mice (3 animals /dose) was performed to 
investigate whether milbemectin is a substrate for the P-glycoprotein transporter. Two strains 
were compared: a wild type strain +/+ and a mutant type strain -/- for the expression of a 
functional mdr 1 P-glycoprotein. The study shows that milbemectin is much more toxic in the 
mice strain that lacks the mdr 1 P-glycoprotein transporter.  
 
 
Medical data 
There are no reports of clinical symptoms or poisoning from the manufacturing or use of 
milbemectin or Milbeknock. 
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Impurities and metabolites 
Several impurities and metabolites were tested for acute toxicity in the mouse, and some 
clinical symptoms were observed. All in vitro genotoxicity studies were negative.  
Milbeknock 1% EC (SI-9009EC) 
Co-formulants 
The product contains aromatic hydrocarbons, thus the product may cause lung damage if 
swallowed.  
 
Acute toxicity 
Milbeknock 1 % EC was of low acute toxicity by the inhalation, oral and dermal exposure. 
 
Irritation and allergy 
Milbeknock 1 % EC is not irritating to the skin or eye, and it is not a dermal sensitiser. 
 
Dermal absorption 
No data were submitted. However, based on the data provided on molecular weights (528.7 
and 542.7) and the log Kow (6.43 and 7.00, for MA3 and MA4 respectively), and according to 
the guidance document on dermal absorption, dermal absorption of 10% is considered.  
Operator, worker and bystander’s exposure 
The exposure, estimated by the UK POEM, exceeds AOEL with 14 % when spraying pomes 
without PPE. The use of PPE reduces the exposure under the AOEL. For spraying in 
greenhouses and in strawberries the AOEL is not exceeded even without use of PPE. For 
bystanders and re-entry workers the estimated exposure was far below AOEL. 
Residues 
Residues are not discussed in this report. 
 
 
5.3.3 ENVIRONMENTAL FATE AND ECOTOXICOLOGICAL EFFECTS 
Environmental fate and behaviour 
Degradation in soil 
The degradation rate of milbemycin A4 is medium to moderate, DT50: 21-82 days, geometric 
mean 36.5 days (arithmetic mean: 43 days). DT90: 69-271 days. Bound residue amounted to 
40 % of AR at maximum and the mineralization to CO2 reached a maximum level of 35 % of 
AR. Two metabolites were identified > 10 % of applied radioactivity (AR); 27-hydroxy-
milbemycin A3/A4 (max 14 % AR of A4) and 27-keto-milbemycin A3/A4 (max 12 % AR of 
A4).The degradation rate (DT50) of the metabolite 27-hydroxy-milbemycin A4 was calculated 
to be 18 days with a DT90 estimated to be 59 days.  
 
At 10 °C the degradation rate of milbemycin A4 is moderate. DT50: 63 days, DT90: 208 days. 
The degradation rate is low under anaerobic conditions, DT50: 556 days in the soil phase. 
DT90 of 1835 days is extrapolated well beyond the study duration. Mineralisation and bound 
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residues amounted to 1.9 and 22 % of AR after 363 days respectively. No metabolites > 5 % 
of AR. 
 
Photolysis can be an important route of degradation for milbemycin A4. DT50 was 7.5 days in 
samples exposed to light and 27 days in dark control samples. Bound residues increased up to 
29 % of AR at the end of the study. Mineralisation amounted to 12 % of AR. No metabolites 
detected > 10 % of AR.  
 
Two acceptable field studies performed in the US have been submitted. The degradation of 
milbemycin A3/A4 is medium to high with DT50: 8-13 days (geometric mean of 8.5 for 
milbemycin A3 and 11.4 for milbemycin A4). Weather conditions are not well described in the 
two studies and assessing the relevance to Norway is difficult. Swedish authorities have 
concluded that the studies were not performed under conditions relevant for Sweden. 
 
Sorption/mobility 
The sorption of milbemycin to soil can be classified as high to very high with Kd: 12-138 
(average 61) and Koc: 1370-4059 (average 2817). 1/n varied from 0.92 to 1.04 with an 
average of 0.98.  
 
The sorption of the two metabolites, 27-hydroxy-milbemycin A4 and 27-keto-milbemycin A4, 
to soil can be classified as high to very high with Kf: 20-94 (average 55) and 59-246 (average 
171) respectively. Koc: 1828-2462 (average 2111) and 5350-7444 (average 6718) 
respectively. 1/n varied from 0.80 to 0.85 for 27-hydroxy-milbemycin A4 and 0.95-1.05 for 
27-keto-milbemycin A4. 
 
Based on the amount of radioactivity in the leachate in an aged column study (1.1-3.3 % of 
AR after 2 days), the mobility can be classified as medium to high in the four tested soils 
(sand, sandy loam, clay loam, silt loam), but neither milbemycin A4 nor any of the major 
degradation products were detected in the leachate. 
 
Degradation in water 
Hydrolysis of 14C- milbemycin A4 was determined at 50 °C at pH 5, 7 and 9. DT50 at the 
different pH values were estimated to be 13, 318 and 241 days respectively. The regression 
coefficients indicate that the DT50 values at pH 7 and 9 are not reliable. 27-hydroxy-
milbemycin A4 and 27-keto-milbemycin A4 were found at levels of 8.2 and 23 % of AR 
respectively at pH 5. 
 
Photolysis is an important degradation pathway for milbemycin A4 when comparing 
irradiated samples to the dark controls. The amount of initially applied radioactivity recovered 
was much higher in the dark controls (96-101 % AR) than in the irradiated samples (15-33 % 
AR). Three metabolites > 5 % AR were also identified. 
 
14C- milbemycin A4 is not readily biodegradable. 
 
Based on a water/sediment degradation the degradation for the whole system can be classified 
as moderate with DT50system: 82-89 days, geometric mean 85 days (arithmetic mean 86 days). 
Bound residues amounted to about 30 % of AR after 100 days in both compartments and 
mineralization was low with only about 6 % after 100 days. The active substance quickly 
dissipated from the water phase to sediment. Metabolites were detected at levels < 5 % AR. 
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Fate in air 
Hydroxyl reaction and ozone reaction half life were estimated to be 16.4 and 13.7 minutes 
respectively for milbemycin A3 and A4. Milbemycin A3 and A4 both have a vapour pressure 
of <1.3x10-5 Pa and a Henry’s law constant of 2.63x10-3 and 1.59x10-3 Pa m3 mol-1 
respectively indicating that significant volatilization is unlikely to occur. 
Exposure 
PIEC (predicted initial environmental concentration) in soil has been estimated in different 
crops after either one or two applications. Time Weighted Averages and PECplateau have also 
been estimated. Worst case PIEC and PECtwa was calculated to be 0.04 mg a.s./kg soil after 
two applications in strawberries. PECplateau was calculated with the Finish PEC calculator to 
be 0.07 mg a.s./kg soil. Only one application and applications in other crops gave lower PEC-
values.  
 
Strawberries were used as a worst case culture in the assessment of groundwater exposure. 
The results of the modelling show that the tested Norwegian and Swedish scenarios gave a 
PECgw << 0.001 µg/l. The modelling was run by The Norwegian Food Safety Authority 
using MACRO (4.4.2) 
 
Groundwater modelling performed in connection with the EU registration was done with 
PEARL v. 1.1.1 and all the relevant FOCUS scenarios (Hamburg-apples in Germany, 
Chateaudun for apples in France, Sevilla for apples in Spain and Piacenza for apples in Italy). 
PECgw was calculated to be << 0.001 µg/l in all scenarios for both milbemycin A4 and the 
two metabolites 27-hydroxy-milbemycin A4 and 27-keto-milbemycin A4.   
 
Models developed by EU’s working group FOCUS estimates predicted environmental 
concentrations in surface water and sediment in different scenarios. The highest PECsw 
values were observed right after the second application, indicating that spray drift is the main 
route of exposure. The highest PIEC for the water and sediment phases are 0.18 µg a.s./l and 
7.9 µg a.s./kg dw respectively in strawberries (leafy vegetables) and 1.3 µg a.s./l and 0.98 µg 
a.s./kg  in the water and sediment phases respectively in pome fruit. Based on the need for 
setting buffer zones and the fact that drift seems to be the major route of exposure to surface 
water, PEC values estimated using the drift tables in Rautmann et al. 2001 were used in the 
risk assessment. In strawberries, with one application, PEC values ranged from 0.21 µg/L 
with a buffer zone of 1 meter to 0.01 µg/l with a buffer zone of 20 meter. In Pome fruit PEC 
ranged from 0.5 to 0.03 µg/l at buffer zones of 5 and 30 meter respectively. In ornamentals 
PECs varied between 0.5 µg/l with a buffer zone of 3 meter and 0.01 µg/l with a zone of 30 
meters. 
Terrestrial organisms 
The active substance milbemectin is a mixture of two microbially produced compounds: 
milbemycin A3 and milbemycin A4, naturally occurring at a ratio of approximately 3:7. All 
Annex II ecotoxicological studies have been conducted with technical milbemectin, 
containing the two components milbemycin A3 and milbemycin A4 in the appropriate relative 
amounts. Where there are indications that the plant protection product is more toxic than what 
can be explained by the content of active substance (or studies are only conducted with the 
product), or identified metabolites are more toxic than the active substance, these calculations 
are included in the summary below. If this is not the case, these values and calculations are 
omitted. 
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Mammals 
Acute toxic to mammals (LD50: 456 mg/kg bw/d). TERacute for the indicator species in 
orchards is estimated as 156 and TERacute is estimated as 574 for the indicator species in 
strawberries. These values do not exceed the trigger (<10).  Moderate reproductive toxicity, 
NOEC: 200 mg/kg. TERchronic is estimated to be 209 in orchards and 904 in strawberries. 
These values do not exceed the trigger (<5).   
 
Birds 
Milbemectin is acutely toxic to birds (LD50: 347 mg/kg bw). TERacute for the indicator 
species in orchards is estimated as 363. For the indicator species in strawberries, TERacute 
values are estimated as 161 and 275 for herbivorous and insectivorous birds, respectively. 
These values do not exceed the trigger (<10).  Milbemectin has moderate dietary toxicity 
(LC50: 1922 mg/kg feed), TERshort-term for all indicator species in all crops are estimated as 
>1000, which do not exceed the trigger (<10). Milbemectin also has a moderate reproductive 
toxicity (NOEC: 150 mg/kg). TERchronic is estimated to be 281 for the indicator species in 
orchards, and 250 for herbivorous birds and 213 for insectivorous birds in strawberry fields. 
These values do not exceed the trigger (<5).  
  
Bees 
Very high contact toxicity to bees (LD50: 0.026 µg/bee). High oral toxicity to bees (LD50: 
0.40 µg/bee). Hazard quotients for contact and oral exposure are estimated to be 680 and 44.2 
for applications in orchards, 896 and 58 for applications in strawberries, and 731 and 47.5 for 
applications in ornamentals. The hazard quotients for contact exposure exceed the trigger 
value (>50) in all crops. 
In order to assess the risk of Milbeknock 1% EC, a semi-field (cage) test has been carried out. 
The results indicated no significant increase in mortality after application of 27.9 g a.s./ha 
(higher than the highest dose applied for in Norway), and no effects on flight intensity, 
behaviour or brood.   
 
Non-target arthropods 
In Tier 1 laboratory acute contact toxicity studies, Milbeknock showed negligible effects on 
parasitoids and ground dwelling predators at relevant application rates. For foliage dwelling 
predators and predatory mites, the trigger of >30% effect is exceeded. 
 
Earthworms 
Milbemectin is acutely toxic to earthworms (LC50corr: 28.5 mg/kg d.w. soil). TERacute for 
orchard and ornamentals is estimated to be 1425 and 950, respectively. TERacute for the 
strawberry scenario is estimated to be 950. These values do not exceed the trigger (<10).  
 
Milbeknock has a high chronic toxicity to earthworms (NOECcorr: 0.11 mg/kg d.w. soil). 
TERchronic for orchards is estimated to be 11. TERchronic for ornamentals is estimated to be 
6. These values do not exceed the trigger (<5). TERchronic for strawberries is estimated to be 
3. This value exceeds the trigger (<5). TERchronic for strawberries recalculated based on a 
single application results in a TER of 6 which does not exceed the trigger. 
 
Microorganisms 
Neither mineralization nor nitrogen transformation by soil microflora of soils treated with 
milbemectin up to 75 g a.s./ha (3 x the maximum expected concentration) differed from 
untreated soils by greater than 25 % (trigger) after 28 days.  
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Terrestrial plants 
Twenty tests are available for a number of crop species. In all treatments effects on 
emergence, shoot length and shoot weight were below the trigger of > 50% effect at the 
maximum application rate.  
Aquatic organisms 
All PEC-values below are based on single application drift values from Rautmann et al. 
(2001), since FOCUS modeling has shown that drift gives the highest PEC-values. TER 
calculations have been performed mostly on single species tests, but also with the microcosm 
study (for invertebrates). 
 
Fish 
Milbemectin showed extreme acute toxicity to fish (96h LC50: 4.4-35 µg a.s./L) and extreme 
chronic toxicity (ELS NOEC: 0.65 µg a.s./L). Milbeknock showed extreme acute toxicity to 
rainbow trout (96h LC50: 5.7 µg a.s./L). All TER calculations for milbemectin, both acute 
and chronic, pass the EU triggers (acute: 100, chronic: 10) with 5-30 meter buffer zones. 
 
Invertebrates 
Milbemectin showed extreme acute toxicity to Daphnia magna (48h EC50: 11 µg a.s./L) and 
extreme chronic toxicity to D. magna (21d NOEC: 0.12 µg a.s./L). Milbeknock showed 
extreme acute toxicity to D. magna (48h EC50: 3.43 µg a.s./L) and very high toxicity to other 
invertebrates (LC50: 49.3-187 µg a.s./L). All TER calculations for milbemectin pass the EU 
trigger with 3-20 meter buffer zones, except TERs for chronic exposure from use in 
ornamentals (TER:9) and pome fruit (TER:4) which fail the trigger (10) even with 30 meter 
buffer zones. 
 
Sediment dwelling organisms 
Milbemectin showed extreme chronic toxicity to Chironomus riparius larvae (28d NOEC: 6.3 
µg/L(spiked water)). Milbeknock showed extreme acute toxicity to Chironomus riparius 
larvae (48h EC50: 30.1 µg a.s./L) and medium acute toxicity to the oligochaeta Tubificidae 
(48h EC50: 1142 µg a.s./L). All TER calculations for milbemectin pass the EU trigger with 1-
5 meter buffer zones. 
 
Aquatic plants 
Milbemectin showed high toxicity to duckweed (14d EC50: >620 µg a.s./L). All TER 
calculations for milbemectin pass the EU trigger with 1-3 meter buffer zones. 
 
Algae 
Milbemectin showed no effects on algae at the highest tested concentration (72h EC50: >2000 
µg a.s./L, NOEC: 2000 µg a.s./L). Milbeknock showed very high toxicity to algae (72h EC50: 
220 µg a.s./L). All TER calculations for milbemectin pass the EU trigger with 1-3 meter 
buffer zones. 
 
Microcosm studies 
A microcosm study representing a plankton-dominated community was submitted. The 
company suggests a NOEAEC of 3.68 µg a.s./L. The Swedish Authority (KemI) suggests a 
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NOEC of 0.058 µg a.s./L, but argues that since it cannot be concluded that the most sensitive 
organisms were present in the microcosms, the study cannot be used to override the results 
from the single species tests. The Norwegian Food Safety Authority agrees that the NOEC 
should be 0.058 µg a.s./L. All TER calculations for milbemectin pass the Nordic/Baltic 
microcosm trigger with 20-30 meter buffer zones, except the TER for use in pome fruit 
(TER:1.8) which fail the trigger (3) even with a 30 meter buffer zone. 
 
Bioconcentration 
Milbemectin shows a moderate potential for bioconcentration; in bluegill sunfish average 
whole fish BCF was 76 and 114 for milbemycin A3 and milbemycin A4, respectively. Rapid 
depuration occurred (CT50: 0.7-1.1 days). 
Dossier quality and completeness 
The dossier is complete and is adequate as a basis for an evaluation of the active substance, 
metabolites and product. 
 
 
5.4 PANEL 2’S ASSESSMENT ON HEALTH 
5.4.1 SUMMARY OF HUMAN TOXICITY/INHERENT PROPERTIES  
In the terms of reference it was stated that Panel 2 in particular should look at the following: 
The human health risk for operators related to the properties of the active substance and the 
product. Panel 2 is in particular asked to look at the following:  
• The degree of oral absorption. 
• Acute toxicity.  
• The reproduction and developmental toxicity.  
• Establishment of reference values (ADI, AOEL and ARfD). 
 
Panel 2 discussed these points in-depth: 
 
The degree of oral absorption 
Based on the milbemycin A4 excretion in urine and bile, the absorption seem to be 47 % of a 
single low dose in both sexes and 30/40% in females/males at a single high dose. This may 
point to a saturated absorption of milbemycin A4 at larger doses..The Norwegian Food Safety 
Authority writes in the evaluation report: “The metabolites found in bile were the same as in 
faeces from non-bile cannulated rats. In urine there were found several dihydroxy- 
metabolites of milbemycin A4. The parent compound was not found in bile samples from any 
group or in faeces from the low dose group. In the high dose group, the mother substance in 
faeces was detected as 31% (males) and 37% (females). Since all mother substance was 
transformed at the low dose, and not all can be accounted for in bile and urine, there seems to 
be another excretion process involved, presumably intestinal secretion”. Furthermore, the 
Rapporteur Member State (RMS, NL)) states in the DAR page 59-60 “it cannot be excluded 
that the actual absorbed amount systemically available is much less (than 47 %). It could be 
that most of the radiolabel had not been present in the post-hepatic systemic circulation. The 
parent compound may have become hydrolysed upon first passage of the liver (first pass 
metabolism) followed directly by excretion into the bile-duct. This mechanism is supported 
by the absence of any parent compound in the urine” 
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The opinion of Panel 2: 
Based on the delivered reports the degree of absorption of milbemectin is questionable. At the 
low dose (2.5 mg/kg bw) most of the compound was metabolized either in the liver or in the 
intestinal. Thus, there seems to be a high first pass metabolism, and thereby low systemic 
uptake.  At the high dose (25 mg/kg bw) the parent compound was detected in faeces (30-
40%). There seems to be a saturated absorption of milbemectin and 30-40% of the dose has 
not been absorbed. However, with regard to the use of milbemectin the absorption at low dose 
is most realistic for the exposure. Panel 2 discussed possible mechanisms that could explain 
the findings of metabolites in the gastrointestinal tract: secretion of metabolites over the 
mucous gland cells in the intestine by P-glycoprotein, excretion into the bile-duct or 
biotransformation of milbemectin in the intestine. Intestinal efflux mediated by transporters 
may be a reason why not all metabolites are accounted for in bile and urine. Panel 2 did not 
find it possible to conclude on which mechanisms that were involved. 
 
Conclusion:   
Panel 2 concludes that the degree of absorption is difficult to determine based on the reported 
studies. The absorption might be as low as 10% (due to high first pass metabolism) or as high 
as 100% (since only metabolites were observed in the intestinal track at the low dose). Panel 2 
proposes to set the absorption to 50%, which is in agreement with EU DAR report (propose 
47%). The difficulty in establishing an exact degree of absorption based on the submitted 
studies is that the mechanism and degree of the first pass metabolism is unclear.  
 
Acute toxicity 
Milbemectin is harmful to rat and mouse in studies by oral gavage single dose. LD50 is 
between 300 -700 mg/kg/bw. It seems that dogs are more sensitive.  
 
The opinion of Panel 2:  
The lethal dose for dogs seems to be between 200 and 400 mg/kg/bw observed in an acute 
toxicity study. LD50 could however not be determined due to few animals. Panel 2 also 
considered a sub-chronic toxicity study with Beagle dogs where 4 dogs died at 200 and 300 
mg/kg bw/day after the first day of administration. Severe treatment-related effects were also 
observed at 100 mg/kg bw/day. Thus, the LD50 value for dogs is likely to be between 100 
and 200 mg/kg bw/ day.  
 
The reproduction and developmental toxicity 
RMS proposed in 2005 classification for developmental toxicity (R63) which was discussed 
in an ECB-meeting (T3) and concluded as follows: “Based on the results from the above 
acute oral toxicity study in two strains of mice, it is apparent that milbemectin is more toxic 
when P-glycoprotein is not expressed. The development of the P-glycoprotein transporter is 
expressed in rats only during late gestation and early lactation whereas in humans P-
glycoprotein expression is fully developed by week 28. Adverse effects of milbemectin noted 
in rats during late gestation and early lactation are not relevant to humans and Sankyo Agro 
therefore considers that the classification of either R63 or R64 is not appropriate for 
milbemectin”.  
 
The reason for this conclusion is that the applicant has investigated the role of the P-
glycoprotein transporter by comparing the acute oral toxicity of milbemectin in two strains of 
CF-1 mice: a wild type strain +/+ and a mutant type strain -/- for the expression of the mdr 1a 
P-glycoprotein. These mice were of the same two strains used to show the importance of the 
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P-glycoprotein transporter in expression of the toxicity of abamectin. Doses were selected 
according to the criteria in OECD 425 (Up and Down procedure). Milbemectin was more 
toxic in the mutant strain of mice. The NOAEL for clinical signs of toxicity and mortality in 
wild type mice were 100 and 900 mg/kg respectively, whereas in the mutant mice the 
NOAEL for clinical signs of toxicity and mortality were only 11 and 100 mg/kg respectively. 
The applicant also tried to conduct a mechanistic study with P-glycogen transporter but did 
not succeed.  
 
The opinion of Panel 2:  
Panel 2 is more sceptical to the applicant’s conclusions than ECB. Panel 2 is of the opinion 
that the documentation is not convincing, and that the CF-1 mice study cannot be used to 
support the argumentation put forward by Sankyo Agro. It is not shown in the documentation 
that the expression of P-glycoprotein has such central role in the developmental toxicity 
following in utero exposure to milbemectin. 
 
Norwegian Food Safety Authority has proposed a NOAEL-value of 12.4 mg/kg bw/day for 
males, for parental toxicity, offspring toxicity and for reproduction. Panel 2 supports the 
proposal. 
 
Establishment of reference values:  
ADI  
An ADI of 0.03 mg/kg bw/day is proposed for milbemectin based on applying a 100-fold 
uncertainty factor to NOAEL of 3 mg /kg bw/day determined in the 90-days and 1-year dog 
studies. The critical effects in these studies were an increase in vomiting and in liver weight. 
The uncertainty factor accounts for interspecies extrapolation (10X) and intraspecies 
variability (10X). The chronic study in the rat has a lower NOAEL than the dog studies, but 
the NOAEL in the rat study was based on marginal effects. 
The opinion of Panel 2:  
Panel 2 supports the choice of ADI. 
AOEL  
An AOEL of 0.014 mg/kg bw/day is proposed for milbemectin based on applying a 100-fold 
uncertainty factor to the NOAEL of 3 mg /kg bw/day determined in the 90-days and 1-year 
dog studies. A correction for incomplete oral absorption of 47 % is applied.  
 
The opinion of Panel 2:  
The degree of oral absorption based on the available studies is uncertain. Panel 2 suggests 
using 50 % oral absorption. The AOEL-value will then be 0.015 mg/kg bw/day 
ARfD  
An ARfD of 0.03 mg/kg bw/day is proposed for milbemectin based on reduced motor activity 
in the acute neurotoxicity study in the rat with a NOAEL of 3 mg/kg bw (extrapolated form a 
LOAEL of 20 mg/kg bw) and a 100 fold uncertainty factor. 
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The opinion of Panel 2:  
The Panel 2 propose an ARfD of 0.067 mg/kg bw/day for milbemectin based on the LOAEL 
value (20 mg/kg bw) with reduced motor activity in the acute neurotoxicity study in the rat. 
The LOAEL value is divided by an uncertainty factor of 300 (10x10x3). The value 3 is an 
extrapolation from a LOAEL value to a NOAEL.  
 
Metabolites and impurities – possible exposure to humans via the environment 
Several impurities and metabolites were tested for acute toxicity in the mouse (Slc:ddY), and 
some clinical symptoms were observed. 
 
5.4.2 RISK CHARACTERIZATION OF HEALTH  
Health risk due to human exposure 
Panel 2 has based their risk characterization for operators on the summary from Norwegian 
Food Safety Authority presented in section 5.3 and on the exposure- and dose-response 
assessments presented in section 5.2.1 by applying the scale of exceed of AOEL. 
Operator, worker and bystander exposure 
Operator exposure 
The operator exposure, when using mechanical spraying in pomes and strawberries, was 
estimated based on the UK POEM and the German model. Exposure, when spraying in 
greenhouses, was estimated by the Dutch model. 
The exposure exceeds AOEL with 14 % when spraying pome fruit without plant protection 
equipment (PPE). The use of PPE reduces the exposure under the AOEL. For spraying in 
greenhouses and in strawberries the AOEL is not exceeded even without use of PPE  
Re-entry worker exposure 
The exposure for re-entry workers harvesting fruits after spraying pomes was estimated by 
Norwegian Food Safety Authority. The estimated exposure was far below AOEL 
Bystander exposure  
For estimating bystander exposure the EUROPOEM II model will be used. These are for 
upward spraying. The estimated exposure was far below AOEL. 
 
Health risk due to residues in products for consumption  
Not included in the terms of reference. 
 
5.5 PANEL 2’S ASSESSMENT OF ENVIRONMENT 
5.5.1 SUMMARY OF THE ENVIRONMENTAL FATE  
Panel 2 has reviewed the actual documentation and points out the following inherent 
properties of the product, the active substance and possible metabolites:  
Degradation and mobility in soils.  
Milbemectin is relative rapidly degraded in soils and has a low mobility due to high soil 
sorption. The sorption is reversible. Panel 2 does not expect leaching to the groundwater.  In 
areas liable to erosion and run-off, transport of milbemectin sorbed to soil particles can occur. 
Two metabolites were identified >10 %. The metabolites have a high soil sorption too. An 
aged column study with 14C-labelled milbemycin indicates medium to high mobility based on 
14C activity in the leachate, but neither milbemycin nor any of the major degradation products 
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were detected in the leachate. Therefore Panel 2 will not accentuate the results from this 
study. Photolysis can be an important route of degradation in surface soil. The degradation of 
milbemycin is medium to high in field dissipation studies, but Panel 2 does not consider the 
field studies performed in the US as relevant for Norwegian conditions.  
 
Bioavailability in soils, sediment and water 
The strong sorption to soil suggests that the bioavailability in soil may be limited. However, 
the opinion of the Panel is that the relatively rapid degradation in soil indicates a significant 
bioavailability. Also, for a substance with such a high log Kow the reported water solubility is 
relatively high, which will contribute to the availability for biological uptake. The toxicity 
observed in the microcosm study indicates high bioavailability also in a water/sediment 
system. 
Degradation in water 
The aerobic degradation for the water/sediment system can be classified as moderate. The 
active substance quickly dissipated from the water phase to sediment. Metabolites were not 
detected at significant levels. The anaerobic degradation is very slow. Photolysis is an 
important degradation pathway in water. 
 
5.5.2 ENVIRONMENTAL RISK CHARACTERIZATION 
The risk characterization of the product’s ecotoxicological effects on terrestrial and aquatic 
organisms made by Panel 2 is based on the summary from the Norwegian Food Safety 
Authority presented in section 5.3 and exposure-, dose/response assessments and risk scale 
described in section 5.2.2. 
 
Effects and risk to terrestrial organisms 
Panel 2 concludes that there is minimal risk for toxic effects of milbemectin to mammals, 
birds, plants and soil microorganisms with the proposed application regime.  
Bees 
Standard laboratory studies show high oral and contact toxicity to bees. The calculated hazard 
quotients for contact exposure exceeds the trigger value with a hazard quotients for contact 
exposure exceeding the trigger value (>50) in all crops. However there was no significant 
increase in mortality and no effects on flight intensity, behaviour or brood in a semi-field 
(cage) test and Panel 2 therefore considers the risk to bees to be minimal.  
Non-target arthropods  
Studies showed negligible acute contact effects of Milbeknock to ground dwelling predators 
at relevant application rates. High effects were seen in acute studies on parasitoids, but not in 
higher tier studies. For foliage dwelling predators and predatory mites, the trigger of >30% 
effect was exceeded by more than 300%. Panel 2 therefore considers the risk for foliage 
dwelling predators and predatory mites to be high and to be minimal for parasitoids and 
ground dwelling predators. 
 
Earthworms 
Milbeknock has a high chronic toxicity to earthworms. TERchronic for use in ornamentals 
and orchards is estimated to be 6 and 11. The TERchronic values for use in strawberries based 
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on two applications of Milbeknock within one growing season failed the trigger value, by  
170 %, while TERchronic based on a single application, results in a TER of 6 and thus pass the 
trigger.(minimal risk) Panel 2 considers the chronic risk to earthworms to be medium with 
two applications. 
 
Effects to aquatic organisms  
Laboratory tests on aquatic organisms have shown that milbermectin is extremely toxic to the 
crustacean zooplankton species Daphnia magna (21 d NOEC = 0.12 µg/l). Tests with other 
invertebrates indicate that insect larvae, gastropoda and tubificidae are less sensitive. The 
same is true for fish and algae.  
A tier 1 risk assessment based on NOEC for Daphnia (0.12 µg/l) and the PEC
 
based on drift 
calculation  with 30 m buffer zone and spraying in Pome fruit (0.03 µg/l) gives a TER = 4, 
which does not pass the EU trigger of 10. The applicant has submitted a microcosm test for 
possible refinement of the aquatic risk assessment. The test was performed in indoor 
laboratory plankton-dominated microcosms with a 30 cm water column above a 3 cm 
sediment layer. The volume of the water was 14 l.  The planktonic communities contained 
microorganisms, algae, cladocerans, copepods, ostracods and rotifers which were obtained 
from natural populations in nutrient-rich systems. The treatments consisted of two 
applications of the formulation Milbeknock EC. The interval between the applications was 10 
days. The test was terminated 70 days after the second application. The test design included 
controls and 6 treatments (0. 058 – 58.9 µg/l), each with three replicates.  
Chemical analysis of the water phase showed that the half-life (DT50) of milbemectin in the 
water phase was 4-10 days. The results from the study were reported based on the initial 
nominal concentrations.  
Calanoid copepods was the most sensitive taxon showing short term effects at 0.23 µg/l 
(NOECpopulation = 0.058 µg/l) and no recovery at 0.92 µg/l. For other copepods and the most 
sensitive Cladocerans short term effects were seen at 3.68 µg/l (NOEC = 0.92 µg/l).  
The applicant has argued that the effects observed on the calanoid copepods should be 
disregarded as it represents only 2% of the total number of taxa identified in the study and 
furthermore the initial numbers of this group were low (less than 10 /l in the controls) which 
would tend to make the population inherently unstable and reduce the potential for recovery. 
The applicant thus suggests a consistent NOECpopulation at 0.92 µg/l, and a NOEAEC (No 
Observed Ecological Adverse Effect Concentration) at 3.68 µg/l. The NOEAEC was selected 
at the highest tested concentration where recovery of all affected populations (except the 
calnoid copepods) had occurred within 32 days after the second application.  
Panel 2 recognizes that the microcosm test is well performed and reported. The microcosm 
study confirms the results of the single-species laboratory tests which have shown that 
milbemectin is extremely toxic to aquatic crustaceans. The fact that the NOECs for various 
Cladoceran species in the microcosm test are higher than the chronic NOEC for Daphnia 
magna from the laboratory reproduction test may be explained by the different exposure 
scenarios in the two test systems. In the microcosms the exposure concentrations in the water 
phase declined after the applications with a halflife of 4-10 days. This decline was probably 
mainly due to partitioning to the sediment, but this cannot be verified since the concentration 
of milbemectin in the sediment was not measured.  
Panel 2 does not support the view of the applicant that the observed effects on calanoid 
copepods should be disregarded since statistically significant effects on numbers of this group 
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were observed on several consecutive sampling occasions after application. Thus, 0.058 µg/l 
should be regarded as NOECpopulation for the study. 
 Panel 2 does not recommend the use of the NOEAEC as proposed by the applicant as a basis 
for risk assessment since the potential of recovery as shown in the microcosm test may not be 
representative for the Norwegian field situation. 
The representativeness of the study for potential Norwegian field scenarios is reduced by the 
following factors: 
• Nutrient-rich communities 
• Potentially sensitive groups e.g. larger crustaceans are lacking   
• High temperature (19-24 °C) which could affect dissipation of milbemectin in the 
water phase and the recovery potential of affected populations 
• Small size of the microcosm units 
The opinion of Panel 2 is that a NOEC from a single microcosm test should not be used 
directly as a basis for risk assessment and that an assessment factor (AF) in the range 2-5 
should be used to account for the uncertainty involved in extrapolation to different real field 
situations. The use of an appropriate AF is a risk management decision but based on the 
representativeness issues indicated above, a minimum assessment factor of 3 should be 
considered. 
Based on the NOECpopulation from the microcosm test (0.058 µg/l) and using an AF=3, the 
environmental concentration should not exceed 0.019 µg/l. This can be compared with the 
corresponding concentration that can be calculated from the NOEC from the Daphnia 
reproduction test in tier 1 (0.12µg/l), which divided by the TER-trigger (10) gives 0.012 µg/l. 
Thus, the outcome of the risk assessment based on the microcosm NOEC gives a similar 
result as an assessment based on tier 1 data.  
 
Risk characterisation to aquatic organisms 
Based on the NOECs for effects on aquatic crusteaceans in Tier 1 tests and from the 
microcosm test, the following risk estimates for various cultures have been calculated.  
Pome fruit 
Exposure concentrations have been estimated based on spray drift during application in pome 
fruit which is considered by Panel 2 to be the worst case scenario in terms of exposure. The 
tier 1 chronic risk assessment with a TER = 4 (with a 30 meter buffer zone) and use of the 
scale described in chapter 5.2.2 gives a medium risk with 250 % exceed of the limit. The 
higher tier calculation with the NOEC from the microcosm study gives a TER = 1.8 and a 
medium risk with 170 % excess of the limit. 
Ornamentals 
Exposure concentrations have been estimated based on spray drift during application in 
ornamentals. The tier 1 chronic risk assessment with a TER = 9 (with a 30 m buffer zone) and 
use of the scale described in chapter 5.2.2 gives a moderate risk with 110 % excess of the 
limit. The higher tier calculation with the NOEC from the microcosm study gives a TER = 5.8 
and thus pass the trigger (minimal risk). 
Strawberry 
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Higher tier calculated TERchronic = 5.8 with 20 m buffer zone and therefore indicates a 
minimal risk. 
 
Conclusions 
For terrestrial organisms, Panel 2 concludes that there is minimal risk for toxic effects of 
milbemectin to mammals, birds, plants, bees, and soil microorganisms with the proposed 
application regime.  
Panel 2 considers the risk for foliage dwelling predators and parasitoids to be high and to be 
medium for earthworms (two applications). 
Panel 2 further concludes that there is a medium risk of toxic effects on aquatic organisms due 
to exposure of milbemectin sprayed in fruits with the proposed application regime, provided 
that a buffer zone of 30 meter to surface water is applied. There are minimal risks of toxic 
effects on aquatic organisms with sufficient buffer zones in other applied crops.  
 
 
5.5.3 QUALITY OF THE SUBMITTED DOCUMENTATION 
Panel 2 is of the opinion that the documentation submitted to VKM is adequate as a basis for 
an evaluation of the active substance, the metabolites, and for the technical material.  
 
6 Conclusion 
6.1 HUMAN HEALTH 
Absorption: 
The degree of absorption is difficult to determine based on the reported studies. The 
absorption might be as low as 10% (due to high first pass metabolism) or as high as 100% 
(since only metabolites were observed in the intestinal track at the low dose). Panel 2 propose 
to set the absorption to 50%, which is in agreement with the EU DAR report (propose 47%). 
Acute toxicity:  
Milbemectin probably has a LD50 for dogs between 100 and 200 mg/kg bw/day. Dogs seem 
to be the most sensitive experimental animal. 
 
The reproduction and developmental toxicity: 
Panel 2 is of the opinion that the documentation of the role of the P-glycoprotein transporter is 
not convincing, and that the CF-1 mice study cannot be used to support the argumentation of 
no developmental toxicity put forward by the applicant.  
 
Establishment of reference values: 
ADI  
Panel 2 supports the choice of ADI of 0.03 mg/kg bw/day 
AOEL  
The degree of oral absorption based on the available studies is uncertain. Panel 2 suggests 
using 50 % oral absorption. The AOEL-value will be 0.015 mg/kg bw/day 
ARfD  
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Panel 2 propose an ARfD of 0.067 mg/kg bw/day for milbemectin based on the LOAEL value 
(20 mg/kg bw) with reduced motor activity in the acute rat neurotoxicity study.  
 
6.2 ENVIRONMENT 
Bioavailability: 
Despite the very high fat-solubility of the active substance, the water solubility is high. The 
opinion of Panel 2 is that the biodegradation in soil is higher than expected. This suggests that 
milbemectin is bioavailable in soil in spite of the high sorption to soil particles. The toxicity 
observed in the microcosm study is also an indication of bioavailability in a water/sediment 
system. 
The microcosm study:  
Panel 2 recognizes that the microcosm test is well performed and reported. The microcosm 
study confirms the results of the single-species laboratory tests which have shown that 
milbemectin is extremely toxic to aquatic crustaceans. Panel 2 does not support the view of 
the applicant that the observed effects on calanoid copepods should be disregarded since 
statistically significant effects on numbers of this group were observed on several consecutive 
sampling occasions after application. Thus, 0.058µg/l should be regarded as NOECpopulation for 
the study, and an assessment factor of 3 should be used. 
Aquatic risk assessment: 
Panel 2 concludes that there is a medium risk of toxic effects on aquatic organisms due to 
exposure of milbemectin sprayed in fruits with the proposed application regime, provided that 
a buffer zone of 30 meter to surface water is applied. There are minimal risks of toxic effects 
on aquatic organisms with sufficient buffer zones in other applied crops.  
  
Terrestrial risk assessment: 
Panel 2 considers the risk for foliage dwelling non-target predators and predatory mites to be 
high and the risk for earthworms to be medium (two applications). 
 
 
 
Attachment 
Attached is The Norwegian Food Safety Authority’s evaluation of the documentation 
submitted by the applicant, following application for registration of the acaricide/insecticide 
Milbeknock (milbemectin) 2011 (www.Mattilsynet.no).  
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